Session 1091: Immunobiology

Date: 4 February 2004, Time: 11:30 - 13:30
Location: Room 1

Oral Presentations

Time	Number	Title / Authors / Affiliations
11:30	338	Topical tacrolimus potentiates carcinogenesis in mouse skin and reduces the lymph node CD4/CD8 ratio Y Niwa MD PhD^a, T Terashima MD^b, H Sumi MD^c ^aNiwa Institute for Immunology, Tosashimizu, Kochi, Japan, ^bDepartment of Dermatology, Osaka City University Medical School, Osaka, Japan, ^cDepartment of Internal Medicine, National Cancer Center Hospital East, Kashiwa, Japan
11:45	339	Regulation of B cell development by PLC-g2 T Kurosaki MD PhD Kansai Medical University and RIKEN Research Center for Allegy and Immunology, Moriguchi, Osaka, Japan
12:00	340	Necessity of immune recognition and control of a human organ stem cell circulating in blood as a monocyte, in order to avoid some proliferating diseases. ML Labat PhD^a, G Mouthon DMV PhD^b, M Pouchelet PhD^c, N Gouhier^b, F Escaig^b, P Boireau DMV PhD^a (a) UMR 956 Ecole Nationale Vétérinaire d'Alfort (ENVA), France, (b) Laboratoire de Chimie Physique Biologiques et Médicales, ENVA, France, (c) Laboratoire Audiovisuel, INSERM, Le Vésinet, France.
12:15	341	The mechanisms controlling the recognition of tumor and virus infected cells by natural killer cells TI Arnon^a, A Porgador PhD^b, O Mandelboim PhD^a ^aThe Hebrew University of Jerusalem, Jerusalem, Israel, ^bBen-Gurion University, Beer-Sheva, Israel
12:30	342	Research on the changes of endocrine hormones in mammary cancer and hyperplasia of mammary glands C Chen BSc Physician director Oncology department of Xiamen First Hospital
12:45	343	Telomere length maintenance involvement in gastrointestinal cancer M Aragona MD, S Panetta ScD, M Morelli ScD, CA Buda MD, FL Campagna ScD, T Comito MD, M Iorfida MD, G Altavilla MD, F La Torre MD Medical Oncology Unit, Human Pathology Department. University of Messina. Messina, Human Pathology Department., Italy

Poster Presentations

Number	Title / Authors / Affiliations
355	Generation of primary antigen-specific immune response to SFV-based vaccine in a trimera model B Ni PhD, B Zhu PhD, Z Lin PhD, L Zou MD, D Ciommo PhD, R Bremner PhD, Z Jia PhD, W Zhou, J Zhao MD, L Wang PhD, Y Wu PhD MD prof Bing Ni,Zhihua Lin, Liyun Zou, Zhengcai Jia, Wei Zhou, Jianping Zhao, Li Wang, Yuzhang Wu: Institute of Immunology, Third Military Medical University, Chongqing 400037, China Bo Zhu: Cancer Center of PLA, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China David P Diciommo, Rod Bremner: Cellular and Molecular Division, Toronto Western Research Institute, University of Toronto, Ontario, Canada, M5T 2S8
356	Targeting apoptotic tumor cells to Fcgamma receptors provides efficient and versatile vaccination against tumors by dendritic cells K Akiyama MD PhD^a,b, S Ebihara^a, A Yada^a, K Matsumura^a, S Aiba MD PhD^c, T Nukiwa MD PhD^b, T Takai PhD^a ^aDepartment of Experimental Immunology and the CREST Program of JST, ^bDepartment of Respiratory Oncology and Molecular Medicine; Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan, ^cDepartment of Dermatology, Tohoku University School of Medicine, Sendai, Japan
357	Anti-tumor Immunity and Different Way of Clustering of LMP/TAP/MHC Genes in Vertebrates MD Bubanovic^a, S Najman MD PhD^b (a)Department of Obstetrics and Gynecology – “Medica Center” - Nis, Serbia and Montenegro; (b)Institute for Biology, University Medical School – Nis, Serbia and Montenegro.
358	Autoimmunity and Alloimmunity – by Products of Adoptive Immunity and Sources of Anti-tumor Immunity Failure MD Bubanovic^a, S Najman MD PhD^b (a) Department of Obstetrics and Gynecology – “Medica Center” - Nis, Serbia and Montenegro; (b) Institute for Biology, University Medical School – Nis, Serbia and Montenegro.
359	Purification, characterization and molecular cloning of novel cancer-reactive heavy-chain antibodies against tandem repeat region of MUC1 F Rahbarizadeh MSc^a, MJ Rasaee PhD^a, M Forouzandeh PhD^b, AA Allameh PhD^a, SA Narang PhD^c ^aDepartment of Clinical Biochemistry, School of Medical Sciences, ^bDepartment of Medical Biotechnology, School of Medical Sciences; Tarbiat Modarres University, Tehran, I.R. Iran, ^cInstitute for Biological Sciences, National Research Council of Canada, Ottawa, Ontario, Canada
360	Chemotherapy-induced changes of perforin expression in cytotoxic T lymphocytes and natural killer cells of colon carcinoma patients MD Mrakovčić-Šutić PhD^a, M Petković MD PhD^b, G Zamolo MD PhD^c, MD Belac-Lovasić^b, Č Milin Ing PhD^a, B Radošević-Stašić MD PhD^a, D Rukavina MD PhD^a ^aDepartment of Physiology and Immunology, ^cDepartment of Pathology; Medical School, University of Rijeka, Rijeka, Croatia, ^bDepartment of Radiotherapy and Oncology, Clinical Hospital Center, Rijeka, Croatia
361	Overexpression of intrahepatic NKT cells increases the cell-mediated cytotoxicity against tumor cell lines B Radošević-Stašić MD PhD, MD Mrakovčić-Šutić PhD, M Šimin MD, D Rukavina MD PhD Department of Physiology and Immunology, University of Rijeka, Medical School, Rijeka, Croatia
362	The expression of leukocyte membrane molecules on leukemia/lymphoma cells KJ Koubek PhD Institute of Hematology and Blood Transfusion, Prague 2, Czech Republic
363	Characterisation of dendritic cells from the omentum in ovarian cancer E Todorovic^a,a, PA Bedford MSc^a, S Islam Phd^a, KS Raju MD^b, SC Knight Phd^a ^aAntigen Presentation Research Group, Imperial College London, Northwick Park & St Mark’s campus, Harrow, United Kingdom, ^bDepartment of Gynecology, Guys and St.Thomas’ NHS Trust, London, United Kingdom
387	Immunotoxicity testing procedures in animals and humans A Veraldi DSc, MPH Bolejack, L Miligi DSc, S Costantini MD Environmental-Occupational Epidemiology Unit, Centre for Study and Prevention of Cancer, Firenze Italy